YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Co-founder, former CEO to buy 23andMe

Posted online

The co-founder and former CEO of 23andMe has inked a deal to buy the company.

Anne Wojcicki's TTAM Research Institute nonprofit bid $305 million for 23andMe’s assets via bankruptcy proceedings. Regeneron Pharmaceuticals had bid $256 million.

“I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome,” said Wojcicki, who stepped down as 23andMe's CEO when the company filed for bankruptcy in March.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences